↓ Skip to main content

Glioma targeted therapy: insight into future of molecular approaches

Overview of attention for article published in Molecular Cancer, February 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Readers on

mendeley
219 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Glioma targeted therapy: insight into future of molecular approaches
Published in
Molecular Cancer, February 2022
DOI 10.1186/s12943-022-01513-z
Pubmed ID
Authors

Keyang Yang, Zhijing Wu, Hao Zhang, Nan Zhang, Wantao Wu, Zeyu Wang, Ziyu Dai, Xun Zhang, Liyang Zhang, Yun Peng, Weijie Ye, Wenjing Zeng, Zhixiong Liu, Quan Cheng

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 219 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 219 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 20 9%
Student > Bachelor 20 9%
Researcher 13 6%
Other 10 5%
Student > Master 10 5%
Other 25 11%
Unknown 121 55%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 30 14%
Medicine and Dentistry 19 9%
Pharmacology, Toxicology and Pharmaceutical Science 10 5%
Unspecified 7 3%
Immunology and Microbiology 7 3%
Other 23 11%
Unknown 123 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 January 2024.
All research outputs
#3,097,379
of 25,192,722 outputs
Outputs from Molecular Cancer
#211
of 1,898 outputs
Outputs of similar age
#73,877
of 520,281 outputs
Outputs of similar age from Molecular Cancer
#18
of 73 outputs
Altmetric has tracked 25,192,722 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,898 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 520,281 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 73 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.